PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
02-Aug-2022 Defence Therapeutics Inc.: BREAKTHROUGH DISCOVERY: ACCUTOXTM EFFECTIVELY KILLS CANCER CELLS BY DIRECTLY ELICITING DNA DAMAGE Defence Therapeutics Inc.
02-Aug-2022 Kerecis, the Medical-Fish-Skin Company, Completes $100 Million Financing from LEGO Owner KIRKBI and Others Businesswire
02-Aug-2022 Ligand Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Businesswire
02-Aug-2022 CORRECTING and REPLACING Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO® Businesswire
01-Aug-2022 DiaMedica Therapeutics to Participate in the BTIG Biotechnology Conference 2022 Businesswire
01-Aug-2022 Fabrinet to Announce Fourth Quarter and Fiscal-Year 2022 Financial Results on August 15, 2022 Businesswire
01-Aug-2022 Adicet Bio to Present at Upcoming Investor Conferences Businesswire
01-Aug-2022 Henry Schein Appoints Trinh Clark and Leigh Benowitz to Executive Management Committee Businesswire
01-Aug-2022 Aerie Pharmaceuticals Announces First Participant Dosed in the COMET-3 Study of AR-15512 for the Treatment of Dry Eye Disease Businesswire
01-Aug-2022  Arcturus Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 9, 2022 Businesswire
01-Aug-2022 Transcat Reports Strong First Quarter Results on 23% Service Revenue Growth and Solid Gross Margin Expansion Businesswire
01-Aug-2022 MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) Businesswire
01-Aug-2022 MAIA Biotechnology Announces Closing of Initial Public Offering Businesswire
01-Aug-2022 Hunter Shkolnik, Napoli Shkolnik Partner, and Opioid PEC Negotiating Team Colleagues Set Stage for $6 Billion TEVA and AbbVie/Allergan Opioid Settlement Businesswire
01-Aug-2022 Enochian Biosciences Inc. Shareholder Update: Robbins LLP Reminds Investors of Class Action Against Enochian Biosciences Inc. (ENOB) Businesswire
01-Aug-2022 Frazier Healthcare Partners Announces Amy DuRoss as Senior Advisor Businesswire
01-Aug-2022 Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital Businesswire
01-Aug-2022 Cohesity Named a Leader for the Third Consecutive Time in the 2022 Gartner® Magic Quadrantâ„¢ for Enterprise Backup and Recovery Software Solutions Businesswire
01-Aug-2022 Tevogen Bio Announces Positive Safety Results Upon Completion of Patient Enrollment in Proof-of-Concept Clinical Trial of T cell Therapy for Elderly or High-Risk COVID-19 Patients Businesswire
01-Aug-2022 GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine Samsung Biologics